□ 本报记者杨易臻 在推动科技创新和产业创新融合上打头阵。——摘自省委《建议》 在苏州高新区的一间实验室里，屏幕上清晰显示一只小鼠大脑深处毛细血管的实时影像，在直径最细仅 7微米的毛细血管内，血流轨迹清晰可见。这正是中国科学院苏州生物医学工程技术研究所(下称"苏州 医工所")团队自主研发的无创脑机接口技术成果。 脑机接口被称为大脑和机器之间的"翻译官"。无创脑机接口由于安全、便捷的特性，应用场景更为普 遍，这也是苏州医工所团队主攻的方向。如何让这一前沿技术走向产业实践？苏州医工所的科研团队正 通过跨学科的协同攻关，推开阻碍脑机接口落地的"三道门"。 无创脑机接口要想走进临床，第一道门槛是"采集难"。传统柔性电极是块状或膏状，在佩戴时容易脱 落，且患者还需忍受剃发的心理负担。苏州医工所生物材料与干细胞研究室研究员李天独辟蹊径，研发 出基于天然明胶的温控相变导电凝胶。 李天打了个生动的比方："大家都吃过的猪皮冻，室温下是液体，低温环境中会凝结成固体。"团队研发 的材料加热后呈液态，能轻松浸润头皮；常温下会迅速转变为固态凝胶，牢牢"抓"住头皮与电极。由 此，使用者不需要剃发，电极也能避免运动干扰，显著提升佩戴舒适度 ...

证券代码：300832 证券简称：新产业 编号：2025-012 1 深圳市新产业生物医学工程股份有限公司 投资者关系活动记录表 | | □特定对象调研 □分析师会议 | | | | | --- | --- | --- | --- | --- | | 投资者关系 | □媒体采访 □业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | 活动类别 | ☑现场参观 | | | | | | ☑其他 | 线上交流、华创证券策略会、天风证券策略会、东方证 | | | | | 券策略会 | | | | | 参与单位名 称及人员姓 | 共计 36 家机构，50 | | 名参会人员，详见附件《与会机构名单》 | | | 名 | | | | | | 时间 | 2025 年 12 月 | 2 日-12 | 月 31 日 | | | 地点 | 深圳市坪山区坑梓街道金沙社区锦绣东路 | | 23 | 号新产业生物大厦 | | | 等； | | | | | 上市公司接 | 董事长兼总经理 饶微 | | | | | 待人员姓名 | 副总经理兼董事会秘书 张蕾 | | | | | | 投资者关系负责人 吕宇宁 | ...

编辑丨王多鱼 排版丨水成文 气管 是典型的复合组织器官，兼具软骨力学支撑、血管供养与上皮屏障功能，其再生过程并非一次性 "搭 建完成"，而是在呼吸牵张、免疫反应和组织重塑的共同作用下持续推进。如何在这一动态环境中实现稳定 而有序的气管再生，始终是组织工程领域的核心挑战。 长期以来，多数工程化气管研究聚焦于初始结构设计，而材料在体内再生过程中是否、以及如何持续参与 组织调控，仍缺乏系统性证据。 近日， 同济大学附属上海市肺科医院 陈昶 教授、复旦大学 俞麟 教授、同济大学附属上海市肺科医院 孙 维言 医师作为共同通讯作者 （同济大学附属上海市肺科医院 汤海 医师、复旦大学博士生 王翰宬 、同济 大学附属上海市肺科医院 孙维言 医师、同济大学博士生 陈羿 为该论文第一作者） ，在 Nature 子刊 Nature Communications 上发表了题为： A bio-adaptive physical hydrogel enables dynamic tissue engineering for tracheal reconstruction 的研究论文。 该研究提出了 动态组织工程 （ Dynamic Ti ...

深圳市新产业生物医学工程股份有限公司 投资者关系活动记录表 证券代码：300832 证券简称：新产业 编号：2025-011 1 深圳市新产业生物医学工程股份有限公司 投资者关系活动记录表 附件： 与会机构名单 | Abu Dhabi Investment Authority | 国联基金管理有限公司 | | --- | --- | | Alpines Capital (HK) Limited | 海通国际资产管理（香港）有限公司 | | Credit Suisse (Hong Kong) Limited | 宏利基金管理有限公司 | | Credit Suisse Asset Management | 华泰资产管理有限公司 | | (International) Limited | | | Fountaincap Research & Investment (Hong | 华夏基金管理有限公司 | | Kong) Co., Ltd. | | | Gic Special Investments Pte Ltd | 汇添富基金管理股份有限公司 | | Goldman Sachs Asset Management ...

Core Viewpoint - A novel non-invasive method for brain stimulation using microelectrodes delivered via immune cells has been developed, potentially revolutionizing the treatment of neurological diseases without the need for invasive surgery [1][2][3]. Group 1: Research Background - Traditional treatments for brain diseases like Parkinson's and epilepsy often require invasive electrode implantation through craniotomy, which carries risks of infection and tissue damage [1]. - Existing non-invasive techniques, such as transcranial magnetic stimulation, lack the spatial resolution needed for precise neuronal control [1]. Group 2: Innovative Technology - The research team introduced a biological "delivery" system named "Circulatronics," utilizing subcellular-sized wireless electronic devices (SWEDs) that are approximately 10 micrometers in diameter [2]. - These devices can be powered wirelessly by near-infrared light, which penetrates several centimeters of tissue, including the skull and brain [2]. Group 3: Experimental Validation - In experiments, the team induced localized inflammation in the brains of mice and injected the "cell-electronic" hybrids, which successfully targeted the inflamed areas [3]. - The devices were activated by external near-infrared light, demonstrating precise stimulation of surrounding neurons with a spatial accuracy of 30 micrometers [3]. Group 4: Future Implications - The technology could potentially eliminate the need for craniotomy in treating various inflammation-related neurological diseases, such as Alzheimer's and post-stroke conditions [3]. - There is potential for broader applications by using different types of immune cells for targeting other diseases in various body parts [3]. Group 5: Current Limitations - The technology is still in early animal testing stages, and improvements in targeting efficiency and long-term safety need to be validated through larger studies [4].

Core Insights - A new method developed by the Medical University of Vienna and Imperial College London allows for precise capture and decoding of hidden neural signals in the residual limbs of upper limb amputees, translating them into accurate movement commands for prosthetic limbs [1][2] Group 1: Research and Development - The research involved implanting a novel 40-channel microelectrode array into three upper limb amputee volunteers, utilizing targeted muscle reinnervation (TMR) surgery to create a new biological interface [1] - TMR surgery reconnects residual arm nerves to remaining muscles, enabling the detection of neural signals originally used to control the hand and arm [1] - The team achieved direct measurement of individual motor neuron activity located in the spinal cord, which transmits movement commands from the brain to the muscles [1] Group 2: Implications for Prosthetics - This breakthrough indicates that future prosthetic limbs will no longer rely on simple muscle contraction patterns for coarse control but will respond to users' finer and more natural movement intentions [2] - The current research lays the groundwork for the development of next-generation wireless implantable devices, which may enable real-time wireless transmission of neural signals to prosthetic hands or other assistive systems [2] - Ultimately, this technology aims to help amputees regain near-natural limb functionality [2]

Core Insights - The third National Postdoctoral Innovation and Entrepreneurship Competition showcased the increasing collaboration between research teams and industries, emphasizing the practical applicability of research outcomes [1][6] - The competition attracted 8,006 projects and 36,000 participants, highlighting the growing interest in innovative technologies across various sectors [4][8] - The event underscored the importance of young scientific talent as a bridge between research and industry, driving innovation and addressing market needs [1][12] Group 1: Event Overview - The competition took place from October 26 to 28 in Quanzhou, Fujian, featuring significant participation from various sectors [1] - A total of 2,100 companies, 20 industry associations, and 13 venture capital institutions engaged with project teams during the event, resulting in 220 intended cooperation projects and 150 signed agreements [8] Group 2: Technological Innovations - A new device developed by a postdoctoral team allows for painless home testing of multiple health indicators, addressing the needs of chronic disease patients [2][5] - The device utilizes 3D microstructure printing technology to enhance the efficiency of biological sample extraction, positioning it as a leading solution in the field [4] Group 3: Industry Collaboration - Companies are increasingly recognizing the value of practical research solutions, as evidenced by the collaboration between Guangdong Lingnan Big Health Ecological Technology Group and South China University of Technology to improve the preservation technology of dried tangerine peel [1][6] - The competition has led to significant interest from venture capital firms, particularly in artificial intelligence projects, indicating a shift towards seed-stage investments focused on innovation potential rather than immediate financial returns [4][8] Group 4: Talent Development Strategies - The event highlighted a shift in talent strategy, emphasizing the need for investment in human resources to drive technological innovation and industry growth [9][10] - Cities like Jinjiang are implementing mechanisms to integrate entrepreneurs and scientists, fostering an environment conducive to innovation and project commercialization [10]

Core Insights - The article highlights the development of a billion-level "Northern Bio Valley" in Dezhou, focusing on the growth of the biotechnology industry through collaboration and innovation [1][2][4] Industry Overview - Dezhou is concentrating on five key areas within the biotechnology sector: biomanufacturing, biomedicine, bio-agriculture, biomedical engineering, and biomass energy, aiming for high-end, clustered, and international development [2][3] - The city has established a clear framework for its biotechnology industry, with 153 enterprises in the sector and projected revenue of 40.4 billion yuan in 2024 [2] Innovation and Collaboration - Innovation is identified as the core driver for overcoming challenges and seizing development opportunities, supported by numerous national and provincial innovation platforms [3] - Dezhou has established long-term collaborations with over 40 universities and research institutions, holding nearly 300 patents related to biopreparation [3] Regional Development - Different regions within Dezhou are focusing on specific areas of biotechnology, such as biomanufacturing in Yucheng and medical devices in Qihe, creating a diverse and collaborative development landscape [4] - The city has mechanisms in place for regular roadshows and result transformation, targeting investors, entrepreneurs, and industry experts to facilitate efficient connections among technology, capital, market, and policy [4] Future Outlook - Dezhou aims to target cutting-edge fields such as synthetic biology, gene cell therapy, and AI pharmaceuticals, with plans to establish high-level innovation platforms and pilot bases [4] - The city is committed to enhancing its industrial cluster development, optimizing its industrial layout, and attracting leading enterprises and major projects to achieve the goal of becoming a billion-level "Northern Bio Valley" [4]

Core Insights - The article highlights the importance of innovation and entrepreneurship among university students, showcasing successful projects from the China International College Students Innovation and Entrepreneurship Competition 2025 [6][15]. Group 1: Entrepreneurship Projects - A project led by Lin Xinzhe from Minjiang University developed high-temperature resistant abalone seedlings, addressing a significant market bottleneck in southern abalone farming [7][8]. - The project achieved a survival rate increase of abalone seedlings from 35% to 70% through optimized oxygen supply technology, significantly reducing transportation losses [8]. - The successful cultivation and promotion of the "Fubao" variety have created a complete model of research, production, supply, and sales, benefiting local farmers [8]. Group 2: Innovation Capability Enhancement - The "pipeline doctor" inspection robot, developed by a team led by Chen Junxi from Beijing Jiaotong University, can save approximately 90% of downtime compared to traditional inspection methods [9][10]. - Participation in innovation and entrepreneurship competitions has helped students transition from technical thinking to user and product-oriented thinking, enhancing their practical skills [10][11]. - The university's entrepreneurship center has incubated 134 student enterprises across various sectors, providing essential support for student-led startups [12]. Group 3: Building Support Platforms - Zhejiang University has been actively engaging in research and exchange activities to foster innovation and entrepreneurship among students, with a focus on creating a supportive ecosystem [13][14]. - The university's collaboration with local industries and the establishment of innovation platforms aim to facilitate the commercialization of research outcomes and support student startups [14]. - The emphasis on cultivating innovative spirit and entrepreneurial skills is seen as crucial for preparing students to meet national and societal needs [14].

Core Insights - The rapid advancements in biomedical engineering are reshaping the future of human health, with innovations such as 3D bioprinting of organs and tissues becoming increasingly feasible [3][20] - Significant breakthroughs include the successful cultivation of a living heart organoid and the discovery of a molecular switch for organ regeneration in mammals [1][4] Group 1: Innovations in Biomedical Engineering - The first living heart organoid over 1 cm in diameter was successfully cultivated in Shanghai, offering new hope for organ transplantation [1][4] - Researchers have developed a method to 3D print active organoids using bioprinting technology, which can replicate the structure and function of real organs [4][20] - The production of bioprinting materials involves creating billions of living cells, which are cultivated in specialized environments to ensure rapid and large-scale expansion [6][8] Group 2: Applications of Bioprinting - Bioprinting technology is being utilized for drug testing, allowing for the creation of mini-tumor models that can simulate patient responses to various treatments [16][18] - The development of in-situ printing techniques enables the direct repair of damaged tissues within the body, such as printing new skin or heart patches [18][20] Group 3: Cross-Disciplinary Collaborations - Collaborative efforts among multiple research institutions have led to the creation of a novel visual prosthetic that allows blind animals to perceive infrared light, showcasing the potential of interdisciplinary research in biomedical engineering [21][27] - The integration of nanomaterials and advanced engineering techniques has resulted in significant improvements in the functionality and efficiency of bioelectronic devices [25][27] Group 4: Strategic Development in Life Sciences - The Chinese government is prioritizing life sciences in its strategic development plans, with initiatives aimed at accelerating the commercialization of cutting-edge technologies in cell and gene therapy [28] - Cities like Shanghai and Shenzhen are actively fostering innovation ecosystems around organoids and biomanufacturing, with ambitious targets for the growth of the biopharmaceutical industry [28]